Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
AssigneeMitsui Chemicals, Inc.
InventorsJunya Fujiwara, Kazuya Sakai, Kenji Kibayashi, Fumiki Shimada, Yoshio Shiga, Shiro Takagi
Life of this patent
Estimating the term…
Abstract
Using a compound selected from compounds represented by the following formula (1) 1 (which include 3-phenyl-2-pyrazoline derivatives and 3-phenyl-tetrahydropyridazine derivatives) and pharmacologically acceptable salts thereof, an agent is provided which can activate glutamic acid transporter and which is useful for prevention and/treatment of cerebral ischemia (cerebral infarct and brain edema), amyotrophic lateral sclerosis (ALS), etc., all caused by glutamic acid toxicity.
Claims10
A compound represented by the following formula (1) or a pharmacologically acceptable salt thereof:
- 7
- [wherein X1, X2, X3, X4 and X5 may be the same or different and are each a hydrogen atom, an alkyl group of 1 to 6 carbon atoms, a trifluoromethyl group, a halogen atom, a nitro group, an alkyloxy group of 1 to 6 carbon atoms, an alkylthio group of 1 to 6 carbon atoms, an alkylsulfinyl group of 1 to 6 carbon atoms or an alkylsulfonyl group of 1 to 6 carbon atoms;
- Y is a hydrogen atom or an alkyl group of 1 to 4 carbon atoms;
- when X5 is an alkyloxy group, an alkylthio group, an alkylsulfinyl group, an alkylsulfonyl group or an alkyl group, X5 and Y may be bonded to each other to form a 6- or 7-membered ring;
- Q is a methylene group or an ethylene group;
- and Ar is a 2-pyrazyl gorup, a 3-quinolyl group or an unsubstituted or Rn-substituted 3-pyridyl group, each represented by one of the following formulas:
- 8
- (R of Rn is an alkyl group of 1 to 6 carbon atoms or a halogen atom;
- n is an integer of 0 to 4;
- and Rn indicates that the number of R is n)].
Dependencies are inferred from the claim text.